| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |